Apligraf
Ended Awarded
- Contract number
- SPE2D626F1727
- Awardee
-
Organogenesis Inc. UEI VKK3WXM4RCZ7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,240
Award facts
- Contract value 100% obligated
- $1,239.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 65 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Canton, MA 02021, USA
Award details come from SAM.gov/FPDS.
About this award
Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract was issued on October 14, 2025, with an ultimate completion date of October 17, 2025, and carries fixed-price pricing with economic price adjustment terms. No set-aside designation was utilized for this award. The contract is funded through the Defense Logistics Agency's Medical Supply Chain operations, which procures specialized medical supplies for military healthcare systems and Department of Defense facilities.
This delivery order represents a continuation of Organogenesis's established role as a key supplier of regenerative medicine solutions to federal healthcare agencies. The company operates under multiple significant indefinite delivery vehicles, including a $49.5 million multiple-award contract with DLA Troop Support Medical running through June 2026. Organogenesis's APLIGRAF product, along with its other offerings such as PURAPLY formulations and surgical implants, provides critical wound treatment and tissue regeneration capabilities supporting medical care for military personnel and the broader defense healthcare system.
Quick answers
Who was awarded contract SPE2D626F1727?
SPE2D626F1727 was awarded to Organogenesis Inc. by Medical Supply Chain (Troop Support) on October 14, 2025.
How much is contract SPE2D626F1727 worth?
The government has obligated $1,240 on SPE2D626F1727.
Is contract SPE2D626F1727 an order under another contract?
Yes. SPE2D626F1727 is a delivery order under SPE2DE21D0005, an indefinite delivery contract.
Was contract SPE2D626F1727 competed?
The extent of competition for SPE2D626F1727 was full and open competition after exclusion of sources. The government received 65 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award